Image

Selective Head-and-neck Cooling on Biomarker Levels and Symptom Rating Following a Boxing Bout

Selective Head-and-neck Cooling on Biomarker Levels and Symptom Rating Following a Boxing Bout

Recruiting
18-40 years
All
Phase N/A

Powered by AI

Overview

Young, healthy elite boxers ≥ 18 years old are recruited. Prior to, and immediately after a competitive boxing bout over 3x2 or 3x3 minutes, blood samples are drawn. Boxers are randomized to intervention or control management by 1:1 allocation prior to baseline testing. After the initial post-fight blood sample is drawn and symptom rating using the sports concussion assessment tool-5 (SCAT-5) has been collected, the boxers receive either acute selective head-and-neck cooling for 45 min, or routine post-fight management. The number of head impacts are counted in all boxers on match video recordings. In both groups, blood samples are drawn 45 minutes after the initial post-bout blood sample, as well as 3 and 6 days post-fight.

Eligibility

Inclusion Criteria:

  1. Male and female elite boxers ≥18 years old
  2. Cleared for participation by the medical staff of the Swedish Boxing Association.
  3. Informed consent by each participant prior to the competitive event
  4. No boxing fights or match sparring during the initial 6 days after their last boxing fight
  5. Signed informed consent.

Exclusion Criteria:

  1. >40 years old or <18 years old
  2. Participation in competitive fights, match-sparring or any training causing additional head impacts during the first six post-fight days after being included in the study.
  3. History of autoimmune neurological diseases or a neurodegenerative disorder.
  4. History of previous traumatic brain injury resulting in an intracranial haemorrhage.

Study details
    Repetitive Head Impact
    Selective Head and Neck Cooling

NCT06386484

Region Skane

3 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.